CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 113 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -99.5% | 13,631 | +0.7% | 0.00% | – |
| Q2 2022 | $40,000 | -68.0% | 13,535 | -66.4% | 0.00% | -100.0% |
| Q1 2022 | $125,000 | +4.2% | 40,225 | +13.3% | 0.00% | +100.0% |
| Q4 2021 | $120,000 | -4.0% | 35,495 | +23.6% | 0.00% | 0.0% |
| Q2 2021 | $125,000 | +54.3% | 28,719 | +61.9% | 0.00% | 0.0% |
| Q1 2021 | $81,000 | -44.1% | 17,739 | -11.2% | 0.00% | -66.7% |
| Q3 2020 | $145,000 | -54.8% | 19,971 | -78.3% | 0.00% | -62.5% |
| Q2 2020 | $321,000 | +146.9% | 91,992 | +407.1% | 0.01% | +60.0% |
| Q2 2019 | $130,000 | -81.9% | 18,142 | -66.4% | 0.01% | -90.6% |
| Q1 2019 | $717,000 | – | 54,003 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |